
What We Offer
TMS Therapy
Spravato
A nasal spray aproved in the U.S. as the first and only monotherapy for adults – resistant depression.
Ketamine Therapy
Medication Evaluation & Management
Telepsychiatry
Counseling &
Therapy
Pharmacogenomic Solutions
Concierge Sports Psychiatry
What Makes Us Different

We Accept Most Major Insurances
















What We Believe
Non-Invasive
Therapy
Holistic
Approach
Patient-Centered
Practice
Spravato (esKetamine)
Spravato is the only FDA-approved treatment used as monotherapy or in conjuction with an oral antidepressants for adults with treatment-resistant depression (MDD with inadequate response to at least 2 oral antidepressants of adequate dose and duration)
Spravato is a unique treatment approach that delivers:
- Results as early as 24 hours and out to 28 days.
- Long-term safety and efficacy out to 5 years.


Ketamine Therapy
Ketamine Infusion therapy involves the administration of Ketamine, a dissociative anesthetic, through an intravenous (IV) drip for therapeutic purposes.
Effective in treatment-resistant depression (TRD) and major depressive disorder (MDD).
Rapid reduction in suicidal ideation (often within hours)
TMS Therapy
Refresh TMS uses a magnetic coil to stimulate regions of the brain associated with depression symptoms.
TMS Therapy is now FDA-Cleared for ages 15 and older, as an adjunct (add-on) to your existing therapy. Nearly 10,000 adolescents have been treated with over 300,000 NeuroStar sessions.
Since 2019 Dr. Francis has treated numerous of patients delivering almost 7000 sessions with the NeuroStar and Magtim TMS treatment.

